AP-1 signaling modulates cardiac fibroblast stress responses

J Cell Sci. 2023 Dec 1;136(23):jcs261152. doi: 10.1242/jcs.261152. Epub 2023 Dec 15.

Abstract

Matrix remodeling outcomes largely dictate patient survival post myocardial infarction. Moreover, human-restricted noncoding regulatory elements have been shown to worsen fibrosis, but their mechanism of action remains elusive. Here, we demonstrate, using induced pluripotent stem cell-derived cardiac fibroblasts (iCFs), that inflammatory ligands abundant in the remodeling heart after infarction activate AP-1 transcription factor signaling pathways resulting in fibrotic responses. This observed signaling induces deposition of fibronectin matrix and is further capable of supporting immune cell adhesion; pathway inhibition blocks iCF matrix production and cell adhesion. Polymorphisms in the noncoding regulatory elements within the 9p21 locus (also referred to as ANRIL) redirect stress programs, and in iCFs, they transcriptionally silence the AP-1 inducible transcription factor GATA5. The presence of these polymorphisms modulate iCF matrix production and assembly and reduce cell-cell signaling. These data suggest that this signaling axis is a critical modulator of cardiac disease models and might be influenced by noncoding regulatory elements.

Keywords: Fibrosis; Gene expression; Gene regulation; Inflammation; Myocardial infarction; Myocardial regeneration.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Fibroblasts / metabolism
  • Fibrosis
  • Heart
  • Humans
  • Myocardium* / metabolism
  • Signal Transduction
  • Transcription Factor AP-1* / genetics
  • Transcription Factor AP-1* / metabolism

Substances

  • Transcription Factor AP-1
  • JunB protein, human